Joyce Yuan, MD
Dermatology · Newport Beach, CANPI 1972940187
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $11,284 of the $12,732 with a category attached, or 88.6%. It is spread thinly across 32 manufacturers, the largest accounting for just 18.0% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $4,891, 5.0 times the $983 reported in 2019.
Across 301 payments — averaging $42.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$2K
- AbbVie$2K
- Regeneron Healthcare Solutions, Inc.$1K
- Sanofi$810
- Galderma Laboratories, L.p.$679
- Johnson & Johnson$662
- plus $5K from 26 others
What the payments were for
- Consulting fees$1,30010%
- Food & beverage$11,28489%
- Education$1481%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 15 | $2,285 |
| AbbVie(2 entities) | 43 | $1,724 |
| Regeneron Healthcare Solutions, Inc. | 26 | $1,430 |
| Sanofi | 20 | $810 |
| Galderma Laboratories, L.p. | 16 | $679 |
| Johnson & Johnson | 18 | $662 |
| Sun Pharmaceutical Industries Inc. | 19 | $631 |
| Incyte Corporation | 23 | $606 |
| Pfizer | 26 | $508 |
| Amgen | 7 | $485 |
| E.r. Squibb & Sons, L.L.C. | 12 | $396 |
| Novartis | 12 | $309 |
| Biofrontera Inc. | 12 | $294 |
| Dermavant Sciences, Inc. | 8 | $286 |
| Bristol Myers Squibb | 2 | $235 |
| Journey Medical Corporation | 2 | $212 |
| Mimedx Group, Inc. | 2 | $191 |
| Janssen Scientific Affairs, LLC | 1 | $141 |
| Boehringer Ingelheim | 6 | $139 |
| Gilead | 1 | $120 |
| Almirall LLC | 5 | $111 |
| Organon | 3 | $110 |
| LEO Pharma Inc. | 4 | $85 |
| Mentor Worldwide LLC | 1 | $44 |
| Mayne Pharma Commercial LLC | 8 | $43 |
| Lilly USA, LLC | 2 | $41 |
| Arcutis Biotherapeutics, Inc. | 2 | $40 |
| Botanix SB Inc | 1 | $27 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $24 |
| Verrica Pharmaceuticals Inc. | 1 | $23 |
| Kyowa Kirin, Inc. | 1 | $22 |
| Medline Industries LP | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$12,732 in reported general payments places this provider in the 85th percentile of 1,875 dermatology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 169 | $2,931 |
| Clobetasol Propionate | 31 | $1,427 |
| Fluocinonide | 26 | $1,087 |
| Triamcinolone Acetonide | 38 | $525 |
| Doxycycline Hyclate | 55 | $454 |
| Mupirocin | 56 | $440 |
| ValacyclovirValacyclovir Hcl | 19 | $391 |
| Clindamycin Phosphate | 15 | $328 |
| Hydrocortisone | 28 | $145 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Newport Beach
- Kevin BelascoNewport Beach$464K
- Navid NamiNewport Beach$302K
- Paul YamauchiSanta Monica$2.9M
- Jennifer SoungSanta Ana$2.8M
- Robert GreenbergLivermore$2.6M
- Neal BhatiaSan Diego$2.5M
- April ArmstrongLos Angeles$2.3M
- Jeffrey CrowleyBakersfield$2.1M
- Jashin WuCorona$2M
- Raja SivamaniSacramento$1.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.